Ironwood Pharmaceuticals Inc

IRWD

Company Profile

  • Business description

    Ironwood Pharmaceuticals Inc is a specialty and generic drug manufacturing company that operates a human therapeutics segment. The company is focused on advancing product opportunities in areas of large unmet need, including irritable bowel syndrome with constipation, chronic idiopathic constipation, hyperuricemia associated with uncontrolled gout, uncontrolled gastroesophageal reflux disease, and vascular and fibrotic diseases. The company considers collaborative licenses, commercial agreements, and acquisition investment to be potential components of its operational growth plan for expanding its research, development, manufacturing, and marketing capabilities.

  • Contact

    100 Summer Street
    Suite 2300
    BostonMA02110
    USA

    T: +1 617 621-7722

    E: [email protected]

    https://www.ironwoodpharma.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 December 2026

    Employees

    253

Stocks News & Analysis

stocks

We raise our near-term gold price assumptions

Our coverage remains overvalued.
stocks

Apple: Gemini partnership lets AI-worried investors breathe a sigh of relief

We believe a competitive—if not leading—AI feature suite will reinforce Apple’s wide-moat mobile device ecosystem.
stocks

ASX share ticks all the popular thematic boxes

The shares are overvalued as investors are overly excited about defence and gold exposure.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,151.800.100.00%
CAC 408,384.3937.190.45%
DAX 4025,391.8828.78-0.11%
Dow JONES (US)49,191.99398.21-0.80%
FTSE 10010,162.7425.390.25%
HKSE26,999.81151.340.56%
NASDAQ23,709.8724.03-0.10%
Nikkei 22554,341.23792.071.48%
NZX 50 Index13,757.71101.660.74%
S&P 5006,963.7413.53-0.19%
S&P/ASX 2008,820.601.20-0.01%
SSE Composite Index4,126.0912.67-0.31%

Market Movers